• FirefoxInstall the new Firefox »
  •  Dow Up 0.08% Nasdaq Up 0.16%

    Cytokinetics, Incorporated (CYTK)

    -NasdaqCM
    7.93 Down 0.02(0.25%) 1:43PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:7.95
    Open:8.01
    Bid:7.87 x 100
    Ask:7.90 x 400
    1y Target Est:13.80
    Beta:1.52
    Earnings Date:May 4 - May 8 (Est.)
    Day's Range:7.77 - 8.07
    52wk Range:3.05 - 13.26
    Volume:216,922
    Avg Vol (3m):554,990
    Market Cap:291.41M
    P/E (ttm):N/A
    EPS (ttm):-0.41
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CYTKDown 0.25%291.41M
    BIIBUp 2.42%99.51B
    LGNDUp 2.44%1.35B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):6.22
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.99
    Quarterly EPS Est (Mar-15) :-0.12
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.53

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cytokinetics, Incorporated, a clinical stage biopharmaceutical company, focuses on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditi... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback